Published in Vaccines (Basel) on August 01, 2017
Hallmarks of cancer: the next generation. Cell (2011) 140.01
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (1991) 14.57
Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N Engl J Med (2013) 10.63
Interactions between the microbiota and the immune system. Science (2012) 10.45
Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (1984) 9.64
Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med (2014) 8.21
FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol (2007) 7.94
Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med (2008) 7.79
Identification of ALK as a major familial neuroblastoma predisposition gene. Nature (2008) 7.38
Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature (2008) 6.80
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med (2010) 6.34
Zika Virus and Birth Defects--Reviewing the Evidence for Causality. N Engl J Med (2016) 6.01
Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med (2009) 5.47
Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol (2007) 5.20
The anaplastic lymphoma kinase in the pathogenesis of cancer. Nat Rev Cancer (2008) 5.07
Germline Mutations in Predisposition Genes in Pediatric Cancer. N Engl J Med (2015) 4.27
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J Exp Med (1999) 4.20
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. Blood (2011) 3.82
Maternal and neonatal tetanus. Lancet (2007) 3.20
The biology of intestinal immunoglobulin A responses. Immunity (2008) 3.18
Postnatal acquisition of endotoxin tolerance in intestinal epithelial cells. J Exp Med (2006) 3.12
Immunosuppressive CD71+ erythroid cells compromise neonatal host defence against infection. Nature (2013) 3.03
Bacterial meningitis in the United States, 1998-2007. N Engl J Med (2011) 2.99
Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells. Immunity (2004) 2.79
Efficacy of neonatal HBV vaccination on liver cancer and other liver diseases over 30-year follow-up of the Qidong hepatitis B intervention study: a cluster randomized controlled trial. PLoS Med (2014) 2.74
Properties of mouse and human IgG receptors and their contribution to disease models. Blood (2012) 2.53
Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene (1990) 2.50
EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas. Lung Cancer (2008) 2.40
Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc. Nature (1984) 2.32
Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. J Clin Invest (2006) 2.16
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med (1998) 2.08
The development of the immune system during pregnancy and early life. Allergy (2000) 2.04
Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils. Nat Immunol (2009) 1.97
Differential inhibitor sensitivity of anaplastic lymphoma kinase variants found in neuroblastoma. Sci Transl Med (2011) 1.96
Vaccines for tumour prevention. Nat Rev Cancer (2006) 1.87
The case for maternal vaccination against pertussis. Lancet Infect Dis (2007) 1.83
The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma. Cancer Cell (2012) 1.81
Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways. Clin Cancer Res (2011) 1.80
Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect Immun (1998) 1.79
Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine (2003) 1.76
Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome. J Clin Oncol (2005) 1.75
Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas. Anticancer Res (2013) 1.68
Germline PHOX2B mutation in hereditary neuroblastoma. Am J Hum Genet (2004) 1.66
2011: the immune hallmarks of cancer. Cancer Immunol Immunother (2011) 1.66
Managing cytokine release syndrome associated with novel T cell-engaging therapies. Cancer J (2014) 1.64
Translocations involving anaplastic lymphoma kinase (ALK). Oncogene (2001) 1.61
ALK protein expression in rhabdomyosarcomas. Histopathology (2002) 1.61
Strategic priorities for respiratory syncytial virus (RSV) vaccine development. Vaccine (2013) 1.56
Maternal vaccination: moving the science forward. Hum Reprod Update (2014) 1.50
Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine (2012) 1.49
Breastfeeding provides passive and likely long-lasting active immunity. Ann Allergy Asthma Immunol (1998) 1.49
Animal models of tumor immunity, immunotherapy and cancer vaccines. Curr Opin Immunol (2004) 1.46
Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine: A Randomized Controlled Trial. Obstet Gynecol (2016) 1.44
Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med (2007) 1.43
Diagnosis of fetal submicroscopic chromosomal abnormalities in failed array CGH samples: copy number by sequencing as an alternative to microarrays for invasive fetal testing. Ultrasound Obstet Gynecol (2015) 1.41
Evidence that FcRn mediates the transplacental passage of maternal IgE in the form of IgG anti-IgE/IgE immune complexes. Clin Exp Allergy (2015) 1.40
Selective adherence of IgA to murine Peyer's patch M cells: evidence for a novel IgA receptor. J Immunol (2002) 1.39
Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice. Cancer Res (2004) 1.38
Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med (2001) 1.35
Dynamics of immunoglobulins at the feto-maternal interface. Rev Reprod (1999) 1.32
Anaplastic lymphoma kinase aberrations in rhabdomyosarcoma: clinical and prognostic implications. J Clin Oncol (2011) 1.28
Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front Immunol (2014) 1.28
Precursor lesions of Wilms tumor: clinical and biological implications. Med Pediatr Oncol (1993) 1.20
Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis. Breast Cancer Res (2011) 1.20
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination. Nat Med (2008) 1.19
Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells. Expert Opin Biol Ther (2012) 1.18
Vaccines for the 21st century. EMBO Mol Med (2014) 1.17
Cytokines in breast milk from allergic and nonallergic mothers. Pediatr Res (2000) 1.15
Breast milk immune complexes are potent inducers of oral tolerance in neonates and prevent asthma development. Mucosal Immunol (2010) 1.14
Secretory IgA possesses intrinsic modulatory properties stimulating mucosal and systemic immune responses. J Immunol (2005) 1.14
Bi-directional cell trafficking between mother and fetus in mouse placenta. Placenta (2006) 1.13
Neonatal cancer. Lancet Oncol (2013) 1.13
Distinct and non-overlapping T cell receptor repertoires expanded by DNA vaccination in wild-type and HER-2 transgenic BALB/c mice. J Immunol (2006) 1.12
Maternal-fetal interaction: preconception immunization in mice prevents neonatal sensitization induced by allergen exposure during pregnancy and breastfeeding. Immunology (2007) 1.11
Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions. J Clin Invest (2004) 1.10
Activated and memory T lymphocytes in human milk. Cytometry (1992) 1.10
Immunoprevention of cancer: is the time ripe? Cancer Res (2000) 1.09
The prenatal origins of cancer. Nat Rev Cancer (2014) 1.09
Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1. J Clin Oncol (2010) 1.09
Maternal immunization. Clin Infect Dis (2014) 1.07
Cancer immunoprevention. Future Oncol (2005) 1.05
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. Cancer Res (2010) 1.05
A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study. Ann Surg (2012) 1.04
Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study. Vaccine (2015) 1.04
Hereditary cancer predisposition in children: genetic basis and clinical implications. Int J Cancer (2006) 1.03
Vaccines in pregnant women and research initiatives. Clin Obstet Gynecol (2012) 1.03
DNA immunization of neonates induces immunity despite the presence of maternal antibody. J Clin Invest (1997) 1.02
HER2 shedding and serum HER2 extracellular domain: biology and clinical utility in breast cancer. Cancer Treat Rev (2011) 1.02
Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring. Circ Res (2006) 1.02
ErbB2 transgenic mice: a tool for investigation of the immune prevention and treatment of mammary carcinomas. Curr Protoc Immunol (2008) 1.00
Neonatal neuroblastoma. Semin Fetal Neonatal Med (2012) 0.99
Cell migration from baby to mother. Cell Adh Migr (2007) 0.99
Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients. Cancer Immun (2010) 0.97
Fetal exposure to intact immunoglobulin E occurs via the gastrointestinal tract. Clin Exp Allergy (2003) 0.97
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. Am J Pathol (2005) 0.97
Kinetics of specific IgA, IgD, IgE, IgG, and IgM antibody responses in rubella. J Med Virol (1985) 0.97
Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancer. PLoS One (2014) 0.96
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. Angiogenesis (2012) 0.96